Who is sponsoring NCT00694759?

NCT00694759 is sponsored by Oregon Health and Science University.

What condition does NCT00694759 study?

NCT00694759 studies Polycystic Ovary Syndrome.

What drugs are being tested in NCT00694759?

Interventions: pioglitazone, metformin, placebo.

What is the status of NCT00694759?

NCT00694759 is currently COMPLETED.

Last reviewed 2019-09-05 · How we verify

Cortisol Regulation in Polycystic Ovary Syndrome

NCT00694759 NA COMPLETED

The purpose of this study is to determine if insulin resistance (how well the body uses insulin and clears sugar) can affect cortisol levels in normal healthy women and women with polycystic ovary syndrome of all body weights.

Details

Lead sponsor	Oregon Health and Science University
Phase	NA
Status	COMPLETED
Enrolment	37
Start date	2006-10
Completion	2011-07

Conditions

Polycystic Ovary Syndrome

Interventions

pioglitazone
metformin
placebo

Primary outcomes

The comparison of body surface area adjusted cortisol production rate (CPR/BSA) before insulin sensitizing therapy in women with PCOS. — Before 6 months of insulin sensitizing therapy
The comparison of body surface area adjusted cortisol production rate (CPR/BSA) after insulin sensitizing therapy in women with PCOS. — After 6 months of insulin sensitizing therapy

Countries

United States